Implantica AG announced earnings results for the third quarter and nine months ended September 30, 2020. For the quarter, the company's Net sales amounted to EUR 27,000. Operating loss increased to EUR 4,790,000 against EUR 748,000 a year ago. Loss after tax amounted to EUR 4,730,000 against EUR 815,000 a year ago. Basic and diluted loss per class A share amounted to EUR 0.10 against EUR 0.02 a year ago. For the nine months, the company's Net sales amounted to EUR 126,000 against EUR 21,000 for the same period last year. Operating loss increased to EUR 7,291,000 against EUR 3,490,000 for the same period last year. Loss after tax amounted to EUR 7,127,000 against EUR 3,602,000 for the same period last year. Basic and diluted loss per class A share amounted to EUR 0.16 against EUR 0.08 for the same period last year.